SIRT2 is essential for LPS-induced microglial cell activation, and inhibiting SIRT2 can reduce microglial cell activation, alleviate neuroinflammation, decrease dopamine neuronal death, and delay Parkinson’s disease neuroinflammation. The gene discussed is SIRT2; the disease is Parkinson disease.